Researchers to share dementia drug with medical companyA Gyeongsang National University research team yesterday made an agreement with local pharmaceutical company Korea Pharma to transfer its technology for producing a natural protein that reduces symptoms of dementia.
The technology is already patented in 30 countries and Korea. Under the agreement, the company will develop a next-generation dementia drug to be commercialized in the next five years, that will effectively treat for kinds of dementia including Alzheimer’s and senile dementia.
According to Kim Myeong-ok, the team’s lead researcher and a professor of neurobiology and abnormal differentiation of the brain, the new drug is the first natural protein that deters regression of a patient’s brain nerve cells, which can treat symptoms and stop the disease’s progress.
More in Industry
70 percent of workers in Korea are burned out, survey says
Boryung's cancer drug line gets GMP certification
Chaebol revert to remote working as Covid-19 cases rise
CSAT survival tools